243 related articles for article (PubMed ID: 24448653)
1. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.
Jia X; Suzuki Y; Naito H; Yetti H; Kitamori K; Hayashi Y; Kaneko R; Nomura M; Yamori Y; Zaitsu K; Kato M; Ishii A; Nakajima T
Dig Dis Sci; 2014 Jul; 59(7):1490-501. PubMed ID: 24448653
[TBL] [Abstract][Full Text] [Related]
2. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
[TBL] [Abstract][Full Text] [Related]
3. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
4. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
5. Importance of detoxifying enzymes in differentiating fibrotic development between SHRSP5/Dmcr and SHRSP rats.
Naito H; Jia X; Yetti H; Yanagiba Y; Tamada H; Kitamori K; Hayashi Y; Wang D; Kato M; Ishii A; Nakajima T
Environ Health Prev Med; 2016 Sep; 21(5):368-381. PubMed ID: 27209494
[TBL] [Abstract][Full Text] [Related]
6. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
Kobayashi Y; Hara N; Sugimoto R; Mifuji-Moroka R; Tanaka H; Eguchi A; Iwasa M; Hasegawa H; Iwata K; Takei Y; Taguchi O
Intern Med; 2017; 56(7):755-762. PubMed ID: 28381740
[TBL] [Abstract][Full Text] [Related]
7. Determination of free and conjugated bile acids in serum of Apoe(-/-) mice fed different lingonberry fractions by UHPLC-MS.
Ghaffarzadegan T; Essén S; Verbrugghe P; Marungruang N; Hållenius FF; Nyman M; Sandahl M
Sci Rep; 2019 Mar; 9(1):3800. PubMed ID: 30846721
[TBL] [Abstract][Full Text] [Related]
8. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
[TBL] [Abstract][Full Text] [Related]
9. Dietary Cholic Acid Exacerbates Liver Fibrosis in NASH Model of Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.
Ichimura-Shimizu M; Watanabe S; Kashirajima Y; Nagatomo A; Wada H; Tsuneyama K; Omagari K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012527
[TBL] [Abstract][Full Text] [Related]
10. Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.
Kitamori K; Naito H; Tamada H; Kobayashi M; Miyazawa D; Yasui Y; Sonoda K; Tsuchikura S; Yasui N; Ikeda K; Moriya T; Yamori Y; Nakajima T
Environ Health Prev Med; 2012 May; 17(3):173-82. PubMed ID: 21853259
[TBL] [Abstract][Full Text] [Related]
11. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.
Moriya T; Kitamori K; Naito H; Yanagiba Y; Ito Y; Yamagishi N; Tamada H; Jia X; Tsuchikura S; Ikeda K; Yamori Y; Nakajima T
Environ Health Prev Med; 2012 Nov; 17(6):444-56. PubMed ID: 22407906
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats.
Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Wang D; Yanagiba Y; Wang J; Ikeda K; Yamori Y; Nakajima T
Dig Dis Sci; 2013 Aug; 58(8):2212-22. PubMed ID: 23824403
[TBL] [Abstract][Full Text] [Related]
14. One-Pot Extraction and Quantification Method for Bile Acids in the Rat Liver by Capillary Liquid Chromatography Tandem Mass Spectrometry.
Asano T; Taki K; Kitamori K; Naito H; Nakajima T; Tsuchihashi H; Ishii A; Zaitsu K
ACS Omega; 2021 Mar; 6(12):8588-8597. PubMed ID: 33817519
[TBL] [Abstract][Full Text] [Related]
15. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
[TBL] [Abstract][Full Text] [Related]
16. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
[TBL] [Abstract][Full Text] [Related]
17. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.
Zhang Y; Klaassen CD
J Lipid Res; 2010 Nov; 51(11):3230-42. PubMed ID: 20671298
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
[TBL] [Abstract][Full Text] [Related]
19. Bile acid levels are increased in the liver of patients with steatohepatitis.
Aranha MM; Cortez-Pinto H; Costa A; da Silva IB; Camilo ME; de Moura MC; Rodrigues CM
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):519-25. PubMed ID: 18467911
[TBL] [Abstract][Full Text] [Related]
20. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
